Rheumatoide Arthritis - T-Zell-unabhängige Mechanismen

Zusammenfassung

Die rheumatoide Arthritis (RA) ist eine chronisch entzündliche Systemerkrankung, manifestiert sich allerdings vor allem an den Gelenken. Sie führt bei vielen Patienten zu einer progressiven Destruktion artikulärer Strukturen, die durch das invasive Einwachsen der hyperplastischen Synovialmembran in den Knorpel und Knochen verursacht wird. Neben Entzündungs- und Immunzellen spielen Fibroblasten eine wichtige Rolle in der Pathogenese der Erkrankung. So sind diese Zellen über ihre Anheftung an den Knorpel und die Produktion matrixzerstörender Enzyme ganz entscheidend am Destruktionsprozess beteiligt. Neuere Untersuchungen belegen zudem eine wichtige Rolle der Fibroblasten bei der Rekrutierung von Entzündungszellen und der Chronifizierung der rheumatoiden Synovitis. Verschiedene Untersuchungen zeigen, dass synoviale Fibroblasten bei RA eine stabile Aktivierung aufweisen, die auch unabhängig vom Entzündungsgeschehen aufrechterhalten wird. Diese führt in einem sich zum Teil selbst unterhaltenden Prozess zur Expression von Adhäsionsmolekülen und matrixabbauenden Enzymen sowie zu Veränderungen im programmierten Zelltod. Diese zentralen Eigenschaften synovialer Fibroblasten bei RA stehen daher im Zentrum aktueller Forschungen zur Pathogenese und stellen potenzielle Angriffspunkte für neue therapeutische Ansätze dar.

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease that shows systemic involvement but primarily affects the joints. In many patients, it results in the progressive destruction of articular structures, caused by invasive growth of the hyperplastic synovial membrane into cartilage and bone. Apart from inflammatory and immune cells, synovial fibroblasts play an important role in the pathogenesis of the disease. These cells are significantly involved in the destructive process through their adhesion to cartilage and the production of matrix-degrading enzymes. Recent data also point to an important role of fibroblasts in the recruitment of inflammatory cells and the chronification of rheumatoid synovitis. A number of studies have demonstrated that RA synovial fibroblasts exhibit features of stable cellular activation that is maintained with or without synovial inflammation. In a self-perpetuating manner, this activation results in the expression of adhesion molecules and matrix-degrading enzymes as well as in alterations in programmed cell death. Current research on the pathogenesis of RA focuses on these central features of RA synovial fibroblasts, thus constituting potential targets for novel therapeutic approaches.

Apoptose - Fibroblasten - Rheumatoide Arthritis

Apoptosis - fibroblasts - rheumatoid arthritis

Literatur

• 1 Ezawa K, Yamamura M, Matsui H. et al . Comparative analysis of CD.  Acta Med Okayama. 1997;  31 25-31
• 2 Matsuoka N, Eguchi K, Kawakami A. et al . Phenotypic characteristics of T cells interacted with synovial cells.  J Rheumatol. 1991;  31 1137-1142
• 3 Meijer C J, Graaff-Reitsma C B, Lafeber G J. et al . In situ localization of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monoclonal antibodies.  J Rheumatol. 1982;  31 359-365
• 4 Chabaud M, Durand J M, Buchs N. et al . Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.  Arthritis Rheum. 1999;  31 963-970
• 5 Firestein G S, Zvaifler N J. How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end.  Arthritis Rheum. 2002;  31 298-308
• 6 Smith J B, Haynes M K. Rheumatoid arthritis - a molecular understanding.  Ann Intern Med. 2002;  31 908-922
• 7 Szekanecz Z, Koch A E, Kunkel S L. et al . Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.  Drugs Aging. 1998;  31 377-390
• 8 Szekanecz Z, Koch A E. Update on synovitis.  Curr Rheumatol Rep. 2001;  31 53-63
• 9 Burmester G R, Stuhlmuller B, Keyszer G. et al . Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?.  Arthritis Rheum. 1997;  31 5-18
• 10 Cutolo M, Sulli A, Barone A. et al . Macrophages, synovial tissue and rheumatoid arthritis.  Clin Exp Rheumatol. 1993;  31 331-339
• 11 Helbig B, Gross W L, Borisch B. et al . Characterization of synovial macrophages by monoclonal antibodies in rheumatoid arthritis and osteoarthritis.  Scand J Rheumatol (Suppl). 1988;  31 61-66
• 12 Kelly P M, Bliss E, Morton J A. et al . Monoclonal antibody EBM/11: high cellular specificity for human macrophages.  J Clin Pathol. 1988;  31 510-515
• 13 Salisbury A K, Duke O, Poulter L W. Macrophage-like cells of the pannus area in rheumatoid arthritic joints.  Scand J Rheumatol. 1987;  31 263-272
• 14 Arend W P, Dayer J M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis.  Arthritis Rheum. 1995;  31 151-160
• 15 Franz J K, Kolb S A, Hummel K M. et al . Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4 + T lymphocytes in rheumatoid arthritis.  Eur J Immunol. 1998;  31 2661-2671
• 16 Smith R S, Smith T J, Blieden T M. et al . Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.  Am J Pathol. 1997;  31 317-322
• 17 Szekanecz Z, Strieter R M, Kunkel S L. et al . Chemokines in rheumatoid arthritis.  Springer Semin Immunopathol. 1998;  31 115-132
• 18 Smith S C, Folefac V A, Osei D K. et al . An immunocytochemical study of the distribution of proline-4-hydroxylase in normal, osteoarthritic and rheumatoid arthritic synovium at both the light and electron microscopic level.  Br J Rheumatol. 1998;  31 287-291
• 19 Zimmermann T, Kunisch E, Pfeiffer R. et al . Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture - primary culture cells markedly differ from fourth-passage cells.  Arthritis Res. 2001;  31 72-76
• 20 Buckley C D, Pilling D, Lord J M. et al . Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation.  Trends Immunol. 2001;  31 199-204
• 21 Cunnane G, Hummel K M, Muller-Ladner U. et al . Mechanism of joint destruction in rheumatoid arthritis.  Arch Immunol Ther Exp. 1998;  31 1-7
• 22 Qu Z, Garcia C H, O’Rourke L M. et al . Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining.  Arthritis Rheum. 1994;  31 212-220
• 23 Fassbender H G. Histomorphological basis of articular cartilage destruction in rheumatoid arthritis.  Coll Relat Res. 1983;  31 141-155
• 24 Firestein G S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?.  Arthritis Rheum. 1996;  31 1781-1790
• 25 Gay S, Gay R E, Koopman W J. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?.  Ann Rheum Dis. 1993;  31 39-47
• 26 Hoyhtya M, Myllyla R, Piuva J. et al . Monoclonal antibodies to human prolyl 4-hydroxylase.  Eur J Biochem. 1984;  31 472-482
• 27 Mosier D E, Gulizia R J, Baird S M. et al . Transfer of a functional human immune system to mice with severe combined immunodeficiency.  Nature. 1988;  31 256-259
• 28 Geiler T, Kriegsmann J, Keyszer G M. et al . A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice.  Arthritis Rheum. 1994;  31 1664-1671
• 29 Rendt K E, Barry T S, Jones D M. et al . Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes.  J Immunol. 1993;  31 7324-7336
• 30 Arend W P. The pathophysiology and treatment of rheumatoid arthritis.  Arthritis Rheum. 1997;  31 595-597
• 31 Okura T, Gong L, Kamitani T. et al . Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.  J Immunol. 1996;  31 4277-4281
• 32 Pap T, Shigeyama Y, Kuchen S. et al . Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis.  Arthritis Rheum. 2000;  31 1226-1232
• 33 Müller-Ladner U, Kriegsmann J, Franklin B N. et al . Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.  Am J Pathol. 1996;  31 1607-1615
• 34 Firestein G S, Zvaifler N J. Anticytokine therapy in rheumatoid arthritis.  N Engl J Med. 1997;  31 195-197
• 35 Fontana A, Hengartner H, Weber E. et al . Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.  Rheumatol Int. 1982;  31 49-53
• 36 Pap T, Müller-Ladner U, Gay R E. et al . Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis.  Arthritis Res. 2000;  31 361-367
• 37 Kyburz D, Rethage J, Seibl R. et al . Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.  Arthritis Rheum. 2003;  31 642-650
• 38 Seemayer C A, Kuchen S, Neidhart M. et al . p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion.  Ann Rheum Dis. 2003;  31 1139-1144
• 39 Kullmann F, Judex M, Neudecker I. et al . Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts.  Arthritis Rheum. 1999;  31 1594-1600
• 40 Li J, Yen C, Liaw D. et al . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.  Science. 1997;  31 1943-1947
• 41 Steck P A, Pershouse M A, Jasser S A. et al . Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.  Nat Genet. 1997;  31 356-362
• 42 Teng D H, Hu R, Lin H. et al . MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.  Cancer Res. 1997;  31 5221-5225
• 43 Pap T, Franz J K, Hummel K M. et al . Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.  Arthritis Res. 2000;  31 59-64
• 44 Takahashi Y, Lallemand-Breitenbach V, Zhu J. et al . PML nuclear bodies and apoptosis.  Oncogene. 2004;  31 2819-2824
• 45 Tamura M, Gu J, Matsumoto K. et al . Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.  Science. 1998;  31 1614-1617
• 46 Di Cristofano A, Kotsi P, Peng Y F. et al . Impaired Fas response and autoimmunity in Pten+/- mice.  Science. 1999;  31 2122-2125
• 47 Marok R, Winyard P G, Coumbe A. et al . Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue.  Arthritis Rheum. 1996;  31 583-591
• 48 Miagkov A V, Kovalenko D V, Brown C E. et al . NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.  Proc Natl Acad Sci USA. 1998;  31 13 859-13 864
• 49 Georganas C, Liu H, Perlman H. et al . Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-κ B but not C/EBP β or c-Jun.  J Immunol. 2000;  31 7199-7206
• 50 Li P, Sanz I, O’Keefe R J. et al . NF-κ B regulates VCAM-1 expression on fibroblast-like synoviocytes.  J Immunol. 2000;  31 5990-5997
• 51 Miagkov A V, Kovalenko D V, Brown C E. et al . NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.  Proc Natl Acad Sci USA. 1998;  31 13 859-13 864
• 52 Hummel K M, Petrow P K, Franz J K. et al . Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction.  J Rheumatol. 1998;  31 1887-1894
• 53 Krane S M, Conca W, Stephenson M L. et al . Mechanisms of matrix degradation in rheumatoid arthritis.  Ann NY Acad Sci. 1990;  31 340-354
• 54 Martel-Pelletier J, Welsch D J, Pelletier J P. Metalloproteases and inhibitors in arthritic diseases.  Best Pract Res Clin Rheumatol. 2001;  31 805-829
• 55 Firestein G S, Paine M M. Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium.  Am J Pathol. 1992;  31 1309-1314
• 56 Maini R, St C lair EW, Breedveld F. et al . Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.  Lancet. 1999;  31 1932-1939
• 57 Okada Y, Gonoji Y, Nakanishi I. et al . Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium.  Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;  31 305-312
• 58 Gouze J N, Bianchi A, Becuwe P. et al . Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κ B pathway.  FEBS Lett. 2002;  31 166-170
• 59 Mengshol J A, Vincenti M P, Brinckerhoff C E. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways.  Nucleic Acids Res. 2001;  31 4361-4372
• 60 Jovanovic D V, Martel-Pelletier J, Di Battista J A. et al . Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis.  Arthritis Rheum. 2000;  31 1134-1144
• 61 Ravanti L, Toriseva M, Penttinen R. et al . Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor β via p38 mitogen-activated protein kinase.  FASEB J. 2001;  31 1098-1100
• 62 Han Y P, Tuan T L, Wu H. et al . TNF-α stimulates activation of pro-MMP2 in human skin through NF-(κ)B mediated induction of MT1-MMP.  J Cell Sci. 2001;  31 131-139
• 63 Pap T, Nawrath M, Heinrich J. et al . Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis.  Arthritis Rheum. 2004;  31 2794-2802
• 64 Kuchen S, Seemayer C A, Rethage J. et al . The L1 retroelement-related p40 protein induces p38delta MAP kinase.  Autoimmunity. 2004;  31 57-65
• 65 Tolboom T C, Pieterman E, van der Laan W H. et al . Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10.  Ann Rheum Dis. 2002;  31 975-980
• 66 Ashkenazi A, Dixit V M. Death receptors: signaling and modulation.  Science. 1998;  31 1305-1308
• 67 Thornberry N A, Lazebnik Y. Caspases: enemies within.  Science. 1998;  31 1312-1316
• 68 Baier A, Meinecke I, Gay S. et al . Apoptosis in rheumatoid arthritis.  Curr Opin Rheumatol. 2003;  31 274-279
• 69 Hasunuma T, Kayagaki N, Asahara H. et al . Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis.  Arthritis Rheum. 1997;  31 80-86
• 70 Drynda A, van der Laan W H, Verheijen J H. et al . Induction of apoptosis in rheumatoid arthritis synovial fibroblasts (RA-SF) by adenoviral gene transfer with TIMP-3 is facilitated by TNF-α.  Ann Rheum Dis. 2002;  31 73
• 71 Zhang H G, Wang Y, Xie J F. et al . Regulation of tumor necrosis factor α-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt.  Arthritis Rheum. 2001;  31 1555-1567
• 72 Kim G, Jun J B, Elkon K B. Necessary role of phosphatidylinositol 3-kinase in transforming growth factor β-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts.  Arthritis Rheum. 2002;  31 1504-1511
• 73 Irmler M, Thome M, Hahne M. et al . Inhibition of death receptor signals by cellular FLIP.  Nature. 1997;  31 190-195
• 74 Schedel J, Gay R E, Kuenzler P. et al . FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis.  Arthritis Rheum. 2002;  31 1512-1518
• 75 Gostissa M, Hengstermann A, Fogal V. et al . Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.  EMBO J. 1999;  31 6462-6471
• 76 Muller S, Berger M, Lehembre F. et al . c-Jun and p53 activity is modulated by SUMO-1 modification.  J Biol Chem. 2000;  31 13 321-13 329
• 77 Rodriguez M S, Desterro J M, Lain S. et al . SUMO-1 modification activates the transcriptional response of p53.  EMBO J. 1999;  31 6455-6461
• 78 Desterro J M, Rodriguez M S, Hay R T. SUMO-1 modification of IκBα inhibits NF-κB activation.  Mol Cell. 1998;  31 233-239
• 79 Matunis M J, Coutavas E, Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex.  J Cell Biol. 1996;  31 1457-1470
• 80 Muller S, Matunis M J, Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus.  EMBO J. 1998;  31 61-70
• 81 Franz J K, Pap T, Hummel K M. et al . Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis.  Arthritis Rheum. 2000;  31 599-607
• 82 Meinecke I, Mendoza H, Baier A. et al . The SUMO-specific Protease SENP1 Decreases the Recruitment of Apoptosis-inducing Transcriptional Repressor DAXX to Nuclear bodies and Modulates the Susceptibility of Rheumatoid Arthritis Synovial Fibroblasts (RA-SF) to Fas-induced Cell Death.  Arthritis Rheum. 2003;  31 146